山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (2): 23-27.doi: 10.6040/j.issn.1673-3770.1.2016.07
陈晓红
CHEN Xiaohong
中图分类号:
| [1] Machens A, Gimm O, Hinze R, et al. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties[J]. J Clin Endocrinol Metab, 2001, 86(3):1104-1109. [2] Mulligan L M. RET revisited: expanding the oncogenic portfolio[J]. Nat Rev Cancer, 2014, 14(3):173-186. [3] Wells S A Jr, Asa S L, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610. [4] 王笑春, 易凡, 支凯林. 甲状腺髓样癌不同手术方式对预后影响(附46例报告)[J]. 临床军医杂志, 2006,34(3):305-306. [5] Romanchishen A F, Lisovsky O V, Vabalayte K V. Choice of the optimal volume of surgery for patients with sporadic medullary thyroid cancer[J]. Inter J Head Neck Surgery, 2011, 2(1):11. [6] Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer[J]. Br J Surgery, 2008, 95(5):586-591. [7] Sippel R S, Muthusamy K, Herbert C. Current management of medullary thyroid cancer[J]. Oncologist, 2008, 13(5):539-547. [8] Kloos R T, Eng C, Evans D B, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association[J]. Thyroid, 2009, 19(6):565-612. [9] Philip F, Jacob J J, Nihal T, et al. Medullary thyroid carcinoma: a 20-year experience from a centre in South India[J]. Anz J Surgery, 2007, 77(3):130-134. [10] Kandil E, Gilson M M, Alabbas H H, et al. Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid Cancer[J]. Ann Surgical Oncol, 2010, 18(4):1028-1034. [11] Schwartz D L, Vishal R, Stephanie S, et al. Postoperative radiotherapy for advanced medullary thyroid cancer-local disease control in the modern era[J]. Head & Neck, 2008, 30(7):883-888. [12] Call J A, Caudill J S, Mciver B, et al. A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience[J]. Rare Tumors, 2013, 5:e37. [13] Cosma M P, Panariello L, Quadro L, et al. A mutation in the RET proto-oncogene in Hirschsprungs disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B[J]. Biochem J, 1996, 314(Pt 2):397-400. [14] Rossella E, Schlumberger M J, Müller S P, et al. Cabozantinib in progressive medullary thyroid cancer[J]. J Clin Oncol Official J Am Society Clin Oncol, 2013, 31(29):3639-3646. |
| [1] | 刘佳珲,田汝宪,李玉梅,宋西成. 构建铜死亡相关lncRNA模型评估头颈鳞状细胞癌预后[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 49-64. |
| [2] | 缪红利,张妍春,郝琳娜,唐乐,何英楠. 活动性眼弓形虫病临床特征及预后分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 82-89. |
| [3] | 彭中华,陈竹,袁洛花,余绍兰,马玉玲. 原发性鼻腔高级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 95-98. |
| [4] | 李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22. |
| [5] | 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137. |
| [6] | 黄佳丽,刘梓琪,徐娟,陈曦,张立庆,周涵. 咽部梭形细胞鳞状细胞癌的临床及预后分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 94-100. |
| [7] | 李美辰,陈海玲,李阳,马登殿. 下鼻甲黏液囊肿1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 91-94. |
| [8] | 杨开炎, 唐凤珠, 覃启才, 李旭祥, 冯大益, 农丰靖, 杨秋云. 异常纺锤体样小头畸形相关蛋白在鼻咽癌中的表达及其临床意义[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 18-25. |
| [9] | 王凯健,陈雪生,王威. 血小板-淋巴细胞比值与喉鳞状细胞癌预后相关性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 67-73. |
| [10] | 张佳佳,石安妮,邢御,洪玉颖,白鹏. 针刺联合西药治疗全聋型突发性聋1例与文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 88-92. |
| [11] | 张永红,张辉,王彩华,杨欣欣,吴允刚,赵玉凤,庞太忠,李晓瑜. 基于TCGA数据库构建喉鳞状细胞癌免疫相关基因预后模型及筛选靶向分子药物[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 54-62. |
| [12] | 刘楠,逄明杰. 鼻内镜泪囊鼻腔吻合术预后影响因素的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 149-155. |
| [13] | 吴波,黄天德,闫斌,陈伊,汤勇. 焦虑抑郁状态与特发性耳鸣预后的相关性研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 46-52. |
| [14] | 孙永强,宋忠义,王春芳,李晓,傅莹,潘新良. 镫骨肌反射阈存在的突聋患者预后及影响因素[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 7-14. |
| [15] | 韩飞燕,王英. 鼻腔鼻窦神经鞘瘤13例临床分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 21-25. |
|
||